da CancerToday Media Team | Gen 21, 2026 | ctka
ctka-0008 Use of Chemotherapy plus a Monoclonal Antibody (Trastuzumab) against HER2-Positive Metastatic Breast Cancer Use of Chemotherapy plus a Monoclonal Antibody (Trastuzumab) against HER2-Positive Metastatic Breast Cancer Year Uso di Chemioterapia e un Anticorpo...